Accéder au contenu
Merck

Novel polymorphs of the anti-Trypanosoma cruzi drug benznidazole.

Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy (2013-10-01)
Sara Braga Honorato, Jorge Souza Mendonça, Nubia Boechat, Alcemira Conceição Oliveira, Josué Mendes Filho, Javier Ellena, Alejandro Pedro Ayala
RÉSUMÉ

Benznidazole (N-benzyl-2-(2-nitro-1H-imidazol-1-yl)acetamide), is a nitro-heterocyclic drug used in the treatment of Chagas disease. Despite the fact that this drug was released more than 30 years ago, little information about its solid state properties is available in the literature. In this study, it was verified that this drug exhibits three polymorphs, which were characterized in situ by X-ray powder diffraction, thermal analysis, hot stage microscopy and infrared spectroscopy. The thermodynamic relationships among these polymorphs were also discussed.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
N-Benzyl-2-nitro-1H-imidazole-1-acetamide, 97%